...eligible for royalties in other countries. Ligand has a right to terminate the deal if ParinGenix... ...does not complete the first commercial sale of a product within an undisclosed time period. ParinGenix's... ...ODSH in Phase IIb testing to treat COPD. Ligand Pharmaceuticals Inc. (NASDAQ:LGND), San Diego, Calif. ParinGenix Inc....
ParinGenix Inc. , Tucson, Ariz. Business: Cardiovascular Hired: Eric Leire as CEO, formerly president and CEO at APT Therapeutics Inc.
WIR Staff
Cardiovascular...
...eligible for royalties in other countries. Ligand has a right to terminate the deal if ParinGenix... ...does not complete the first commercial sale of a product within an undisclosed time period. ParinGenix's... ...ODSH in Phase IIb testing to treat COPD. Ligand Pharmaceuticals Inc. (NASDAQ:LGND), San Diego, Calif. ParinGenix Inc....
ParinGenix Inc. , Tucson, Ariz. Business: Cardiovascular Hired: Eric Leire as CEO, formerly president and CEO at APT Therapeutics Inc.
WIR Staff
Cardiovascular...